This Week in The Roadhouse Pharmacy

/in /by

THE ROADHOUSE PHARMACY: There’s a great deal of interest in the Bio-tech sector at the moment, so we have opened our own Pharmacy to keep our readers up to speed.

Benitec commences patient dosing

Benitec commences patient dosing

Benitec Biopharma Limited (ASX: BLT) has dosed the first patient in the company’s ‘first in man’, Phase I/II a clinical trial for TT-034, a ddRNAi‐based therapeutic, designed to treat and potentially cure hepatitis C (HCV) with a single injection.
READ MORE…

Mesoblast accelerates Singapore manufacture plans

Mesoblast Limited (ASX: MSB) is bringing forward plans for its commercial manufacturing operations in line with anticipated product launches in the United States and other major markets.
READ MORE…

Imugene appoints Bachem to manufacture cancer vaccine peptide

Imugene Limited (ASX: IMU) has appointed Bachem AG to undertake clinical-grade manufacture of the peptide component of its proprietary therapeutic HER-2+ cancer vaccine HER-Vaxx.
READ MORE…

SomnoMed starts business in Spain and Portugal

SomnoMed Limited (ASX: SOM) announced it will commence marketing the company’s SomnoDent® products from July in Spain and Portugal. READ MORE…

Prima BioMed achievs US patent for CVac technology

Prima BioMed (ASX: PRR) has received a Notice of Allowance from the United States Patent and Trademark Office, protecting the company’s CVac™ technology. READ MORE…